Cancer

Cancer and Nuclear Facilities, Part 2
by National Cancer Institute
All counties with a major nuclear facility that is or once was in operation and went into service before 1982 were included in the survey as study counties. Other adjacent counties that contain one-fifth of the land that lies within a 10-mile radius

When Cancer Returns : Ways You Can Cope, Part 2
by National Cancer Institute
Keeping your children's trust is very important at this time. Children can sense when things are wrong. So it's best to be as open as you can about your cancer. They may worry that they did something to cause the cancer.

Cancer Clusters, Part 2
by National Cancer Institute
Epidemiologists must also consider that a confirmed cancer cluster may not be the result of any single, external cause or hazard. A cancer cluster could be the result of chance, an error in the calculation of the expected number of cancer cases

Cancer: Access to Investigational Drugs
by National Cancer Institute
An investigational drug is one that is under study and is not approved by the U.S. Food and Drug Administration for sale in the United States. The most common way patients receive investigational drugs is by taking part in clinical trials.

Oral Contraceptives and Cancer, Part 2
by National Cancer Institute
Studies have consistently shown that using OCs reduces the risk of ovarian cancer. In a 1992 analysis of 20 studies of OC use and ovarian cancer, researchers from Harvard Medical School found that the risk of ovarian cancer decreased with increasing

Cancer : Getting the Most From Your Follow-up Visits
by National Cancer Institute
How do you get the most from your doctor visits? Here are some ideas that have helped others deal with their follow-up care: Ask someone to come with you to your doctor visit. A friend or family member can help you think about and understand what was said

Your Health Care Team
by National Cancer Institute
Coping with cancer is not an easy thing. The physical effects of illness and treatment can be quite severe, and the emotional and psychological impact of having cancer can be equally challenging.

Cancer Chemoprevention
by National Cancer Institute
Chemoprevention is the use of natural or synthetic substances to reduce the risk of developing cancer, or to reduce the chance that cancer will recur (come back).

New Cancer Treatments Clinical Trials
by National Cancer Institute
During the approval process, the FDA classifies as priority those treatments that offer significant medical advances over existing therapies. But even in non-priority cases, the FDA's goal is that no more than 10 months will pass between when a complete

Angiogenesis
by National Cancer Institute
Cancer researchers studying the conditions necessary for cancer metastasis have discovered that one of the critical events required is the growth of a new network of blood vessels. This process of forming new blood vessels is called angiogenesis.

Cancer: Taking Part in Clinical Trials
by National Cancer Institute
This information may interest you if you have a higher risk for a certain type of cancer than most people, or you may want to learn about ways to prevent cancer. There are two types of prevention clinical trials that study ways to reduce the risk

Physical Activity and Cancer
by National Cancer Institute
Physical activity is any bodily movement produced by skeletal muscles; such movement results in an expenditure of energy. Physical activity is a critical component of energy balance, the term researchers use to describe how weight, diet, and physical

Physical Activity and Cancer, Part 2
by National Cancer Institute
Physical activity probably reduces men's risk for prostate cancer by 10 percent to 30 percent. The likely association between physical activity and prostate cancer is based on a small number of studies that evaluated the role of physical activity in men

Cancer Clusters
by National Cancer Institute
Cancer clusters may be suspected when people report that several family members, friends, neighbors, or coworkers have been diagnosed with the same or related cancer. Some amount of clustering may occur simply by chance.

Cancer in the Family: What It's Like for You
by National Cancer Institute
When someone in your family has cancer, it may mean many things to you. Other people who have been through it say it can be a lot of things: confusing, scary, lonely, and much more.

Rituximab Benefits Younger Patients
by National Cancer Institute
Addition of the drug rituximab (Rituxan, a monoclonal antibody) to a standard chemotherapy regimen for diffuse large-B-cell lymphoma significantly increased survival for patients with good-prognosis disease who were younger than 60.

Practical Matters After Cancer Treatment
by National Cancer Institute
Being a cancer survivor can affect your job, your health insurance, your finances, and other practical matters. Often, your doctor, nurse, or social worker can be a good source for answers to your questions.

Cancer: Access to Investigational Drugs, Part 2
by National Cancer Institute
Patients who do not meet the eligibility criteria for a clinical trial of an investigational drug may be eligible to receive the drug under a mechanism known as a special exception or a compassionate exemption to the policy of administering

Retinoblastoma
by National Cancer Institute
Retinoblastoma is a disease in which malignant (cancer) cells form in the tissues of the retina. The retina is the nerve tissue that lines the inside of the back of the eye. The retina senses light and sends images to the brain by way of the optic nerve.

Cancer : Taking Part in Clinical Trials, Part 2
by National Cancer Institute
A cancer prevention clinical trial that involves people results from a long and careful research process. As with other types of trials, each step, or phase, answers different questions about the sutdy agent which can be a medicine, vitamin, mineral, food